Immunocore Holdings plc financial data

Symbol
IMCR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
90 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
Immunocore Ltd (to 2/1/2021)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50M shares
Common Stock, Shares, Outstanding 50M shares
Entity Public Float 2.7B USD
Common Stock, Value, Issued 135K USD
Weighted Average Number of Shares Outstanding, Basic 50M shares +2.71%
Weighted Average Number of Shares Outstanding, Diluted 50M shares +2.71%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 75.4M USD +26.2%
Cost of Revenue 1.71M USD +393%
Research and Development Expense 51.1M USD +33.8%
Operating Income (Loss) -16M USD -16.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.1M USD +39.8%
Income Tax Expense (Benefit) 1.49M USD +678%
Net Income (Loss) Attributable to Parent -11.6M USD +31.7%
Earnings Per Share, Basic -0.23 USD/shares +34.3%
Earnings Per Share, Diluted -0.23 USD/shares +34.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 505M USD
Marketable Securities, Current 355M USD
Accounts Receivable, after Allowance for Credit Loss, Current 60.2M USD
Inventory, Net 3.46M USD
Other Assets, Current 9.71M USD +168%
Assets, Current 957M USD
Deferred Income Tax Assets, Net 10.1M USD
Property, Plant and Equipment, Net 7.68M USD
Operating Lease, Right-of-Use Asset 32.4M USD
Other Assets, Noncurrent 16.3M USD
Assets 1.02B USD
Accounts Payable, Current 19.9M USD
Employee-related Liabilities, Current 8.63M USD
Liabilities, Current 185M USD
Operating Lease, Liability, Noncurrent 33.4M USD
Liabilities 664M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -34.4M USD
Retained Earnings (Accumulated Deficit) -781M USD
Stockholders' Equity Attributable to Parent 359M USD +2.19%
Liabilities and Equity 1.02B USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.59M USD -144%
Net Cash Provided by (Used in) Financing Activities 396M USD +6351%
Net Cash Provided by (Used in) Investing Activities -430K USD +85.7%
Common Stock, Shares, Issued 50M shares
Common Stock, Par or Stated Value Per Share 0 GBP/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 505M USD +16.9%
Deferred Tax Assets, Valuation Allowance 83.1M USD -3.83%
Deferred Tax Assets, Gross 95.3M USD +3.09%
Operating Lease, Liability 34.8M USD
Depreciation 1.01M USD +6.2%
Payments to Acquire Property, Plant, and Equipment 430K USD -85.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.7M USD -4.19%
Lessee, Operating Lease, Liability, to be Paid 58.7M USD
Property, Plant and Equipment, Gross 61.5M USD +15%
Operating Lease, Liability, Current 1.39M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.81M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 3.82M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 23.9M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.64M USD
Deferred Tax Assets, Operating Loss Carryforwards 74.9M USD +2.54%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.82M USD
Additional Paid in Capital 1.17B USD
Interest Expense 3.24M USD +159%